TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03286582 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT03286582 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01984957 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00173680 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT00169195 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00145522 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT00076050 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02187965 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01760460 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02929095 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00850590 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00538980 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT00525148 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03020758 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01374997 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT02627573 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT00939770 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00107744 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04563702 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02746952 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00498680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00663546 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT06355245 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02626949 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02626949 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02626949 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04036890 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT01584921 — Safety Biomarker (SAF): 51Cr-EDTA
Study NCT03421860 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02271750 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT02271750 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02271750 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT01233102 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02271568 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01897883 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02804971 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03549234 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03491449 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00406471 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01836146 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01409915 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02010905 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02248961 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04279561 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04279561 — Predictive Biomarker (PRD): ARSI mRNA
Genes: ARSI
Study NCT01996774 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01996774 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01724736 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01724736 — Safety Biomarker (SAF): Bacteroidetes phylum
Study NCT00004735 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01352273 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT00040482 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04193566 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02983708 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00484432 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT03182205 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02179047 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02179047 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT02179047 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT03593382 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00004475 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT01695551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00154102 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01963585 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01963585 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04529720 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02915016 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02166905 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT04254497 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01825590 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01825590 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02975505 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03287050 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03287050 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04589910 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT01147952 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01957579 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03620526 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02564263 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04092582 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT05638178 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02000856 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03270007 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03270007 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01752257 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01752257 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03096561 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00098878 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT03100656 — Predictive Biomarker (PRD): EPHX2 mRNA
Genes: EPHX2
Study NCT00019097 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01061177 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01061177 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00289601 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT00005141 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01984424 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03783377 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study NCT03584178 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03367221 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT00660309 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT03711864 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT01421706 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT00450307 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04333706 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01685905 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04488575 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02805868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00444912 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00444912 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00444912 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00444912 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02410122 — Predictive Biomarker (PRD): PROM1 mRNA
Genes: PROM1; PROML1; MSTP061
Study NCT00343759 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00747760 — Predictive Biomarker (PRD): TSHR mRNA
Genes: TSHR; LGR3
Study NCT01466335 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01983813 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04622709 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00532337 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02293954 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00537147 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01941095 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02834000 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03029247 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03436134 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT03747224 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study NCT02795351 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT01101880 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02486497 — Predictive Biomarker (PRD): Solute carrier family 29 member 1
Genes: SLC29A1; ENT1
Study NCT01970046 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02571777 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02155790 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04603456 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT04277533 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT04277533 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04277533 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01096927 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03085173 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01964833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01964833 — Safety Biomarker (SAF): Interleukin 1 alpha
Genes: IL1A; IL1F1
Study NCT01964833 — Safety Biomarker (SAF): Interleukin 1
Study NCT01964833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03547024 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03547024 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03547024 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00828997 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01552096 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00206427 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03877146 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00655577 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00102908 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04419337 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04419337 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04419337 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04419337 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01014052 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT01014052 — Predictive Biomarker (PRD): LRAT mRNA
Genes: LRAT
Study NCT01728584 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT00244010 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03220178 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03220178 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03220178 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03220178 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03674684 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00204815 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06309732 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT02546453 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03558958 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03558958 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01275040 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01275040 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00622401 — Safety Biomarker (SAF): Interleukin 12
Study NCT00856271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04259567 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001405 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01762878 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00386464 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04173585 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT00216814 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00216814 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02231008 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study NCT04236479 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02734602 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT01727999 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT02262832 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02262832 — Surrogate Endpoint (SUR): Serum hemoglobin A1C
Study NCT02262832 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00988559 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03557398 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01823627 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04961931 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04961931 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT04961931 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04961931 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00846625 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00846625 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03350659 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02959216 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT03376802 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00970970 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00970970 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT00970970 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00077961 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00004779 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02928913 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01874405 — Predictive Biomarker (PRD): Liver iron
Study NCT03868046 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03868046 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03868046 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00753467 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00753467 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04051970 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01255917 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT02169505 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00130689 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04375982 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04375982 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03868839 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03868839 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04355520 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04355520 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04355520 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT00588263 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00588263 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00588263 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study NCT00248638 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study NCT01382212 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03017495 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04348097 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00270296 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02312180 — Predictive Biomarker (PRD): PLG mRNA
Genes: PLG
Study NCT05471674 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02470507 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00393029 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00393029 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04924686 — Predictive Biomarker (PRD): NOD2 mRNA
Genes: NOD2; CARD15; IBD1
Study NCT03290092 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03290092 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01269632 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01962896 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01255475 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01311362 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01311362 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00458679 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00458679 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04841460 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01190345 — Predictive Biomarker (PRD): ALDH1A1 mRNA
Genes: ALDH1A1; ALDC; ALDH1; PUMB1
Study NCT04947683 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02367937 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02367937 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04524728 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04524728 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04524728 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04607239 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01408446 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT01161576 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study NCT03467815 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00134238 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03832179 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03160677 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01156870 — Predictive Biomarker (PRD): CA6 mRNA
Genes: CA6
Study NCT01149187 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02761018 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01412515 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03859505 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT03859505 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03859505 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04141033 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01442402 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT01563757 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT04085718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04085718 — Predictive Biomarker (PRD): EMB mRNA
Genes: EMB
Study NCT00150202 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00844402 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02997813 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02577406 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2